Stocks and Investing Stocks and Investing
Wed, March 22, 2023
Tue, March 21, 2023
Mon, March 20, 2023
Sat, March 18, 2023
Fri, March 17, 2023

David Nierengarten Maintained (TSVT) at Buy with Decreased Target to $21 on, Mar 17th, 2023


Published on 2024-10-28 02:18:44 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Maintained "2seventy bio, Inc." (TSVT) at Buy with Decreased Target from $28 to $21 on, Mar 17th, 2023.

David has made no other calls on TSVT in the last 4 months.



There are 3 other peers that have a rating on TSVT. Out of the 3 peers that are also analyzing TSVT, 0 agree with David's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with David


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $28 on, Tuesday, January 24th, 2023
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $28 on, Friday, January 20th, 2023
  • Daina Graybosch of "SVB Leerink" Maintained at Buy with Decreased Target to $34 on, Tuesday, January 10th, 2023